Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. | Breast Cancer Res | 2021 | 34922601 | PubTator, text mining | PubMed |
| The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | 34917609 | PubTator, text mining | PubMed |
| Non-Coding RNA Networks in Pulmonary Hypertension. | Front Genet | 2021 | 34917122 | PubTator, text mining | PubMed |
| LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis. | J Oncol | 2021 | 34912458 | PubTator, text mining | PubMed |
| ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation. | Cancer Cell Int | 2021 | 34906142 | PubTator, text mining | PubMed |
| Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. | Mol Ther Oncolytics | 2021 | 34901389 | PubTator, text mining | PubMed |
| Long Non-coding RNAs LINC01679 as a Competitive Endogenous RNAs Inhibits the Development and Progression of Prostate Cancer via Regulating the miR-3150a-3p/SLC17A9 Axis. | Front Cell Dev Biol | 2021 | 34900992 | PubTator, text mining | PubMed |
| Emerging Roles of Long Noncoding RNAs in Immuno-Oncology. | Front Cell Dev Biol | 2021 | 34900986 | PubTator, text mining | PubMed |
| The Roles and Mechanisms of lncRNAs in Liver Fibrosis. | Front Pharmacol | 2021 | 34899344 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers. | Cancers (Basel) | 2021 | 34885213 | PubTator, text mining | PubMed |
| PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers. | Cancers (Basel) | 2021 | 34885209 | PubTator, text mining | PubMed |
| Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application. | Cancers (Basel) | 2021 | 34885054 | PubTator, text mining | PubMed |
| High-Throughput Sequencing Profiles About lncRNAs and mRNAs of Ovarian Granulosa Cells in Polycystic Ovary Syndrome. | Front Med (Lausanne) | 2021 | 34881258 | PubTator, text mining | PubMed |
| A Novel Curcumin-Based Drug Powder Inhalation Medicine for Chronic Obstructive Pulmonary Disease. | Bioinorg Chem Appl | 2021 | 34880911 | PubTator, text mining | PubMed |
| Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma. | Int J Gen Med | 2021 | 34880662 | PubTator, text mining | PubMed |
| Inhibition of extracellular vesicle-associated MMP2 abrogates intercellular hepatic miR-122 transfer to liver macrophages and curtails inflammation. | iScience | 2021 | 34877493 | PubTator, text mining | PubMed |
| Intricate crosstalk between MYB and noncoding RNAs in cancer. | Cancer Cell Int | 2021 | 34876130 | PubTator, text mining | PubMed |
| Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer. | J Oncol | 2021 | 34873403 | PubTator, text mining | PubMed |
| Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia. | Front Cell Dev Biol | 2021 | 34869365 | PubTator, text mining | PubMed |
| A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer. | Front Cell Dev Biol | 2021 | 34869309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=57